Pholedrine | CAS# 370-14-9 (free base) | Autonomic Agent

MedKoo Cat#: 592616 | Name: Pholedrine

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pholedrine is an Autonomic Agent. It is a a sympathomimetic vasoconstrictive drug which has been used to treat chronic hypotension.

Chemical Structure

Pholedrine

CAS#370-14-9 (free base)

Theoretical Analysis

MedKoo Cat#: 592616

Name: Pholedrine

CAS#: 370-14-9 (free base)

Chemical Formula: C10H15NO

Exact Mass: 165.1154

Molecular Weight: 165.24

Elemental Analysis: C, 72.69; H, 9.15; N, 8.48; O, 9.68

Price and Availability

Size	Price	Availability	Quantity
25mg	USD 650.00

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

877-86-1 (HCl); 370-14-9 (free base)

Synonym

Pholedrine; Veritain; Veritol

IUPAC/Chemical Name

4-(2-(Methylamino)propyl)phenol

InChi Key

SBUQZKJEOOQSBV-UHFFFAOYSA-N

InChi Code

InChI=1S/C10H15NO/c1-8(11-2)7-9-3-5-10(12)6-4-9/h3-6,8,11-12H,7H2,1-2H3

SMILES Code

OC1=CC=C(CC(NC)C)C=C1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Product Data

Product Data

Instruction

View handling instruction

Biological target:

Pholedrine is an Autonomic Agent.

In vitro activity:

TBD

In vivo activity:

TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 165.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

TBD

In vitro protocol:

TBD

In vivo protocol:

TBD

1: Bade R, Ghetia M, Chappell A, White JM, Gerber C. Pholedrine is a marker of direct disposal of methamphetamine. Sci Total Environ. 2021 Aug 15;782:146839. doi: 10.1016/j.scitotenv.2021.146839. Epub 2021 Mar 30. PMID: 33836378. 2: Vevelstad M, Øiestad EL, Nerem E, Arnestad M, Bogen IL. Studies on Para- Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications. Drug Metab Dispos. 2017 Dec;45(12):1326-1335. doi: 10.1124/dmd.117.077263. Epub 2017 Oct 4. PMID: 28978661. 3: Mullany C, Keller PA, Nugraha AS, Wallman JF. Effects of methamphetamine and its primary human metabolite, p-hydroxymethamphetamine, on the development of the Australian blowfly Calliphora stygia. Forensic Sci Int. 2014 Aug;241:102-11. doi: 10.1016/j.forsciint.2014.05.003. Epub 2014 May 20. PMID: 24905152. 4: Kuwayama K, Tsujikawa K, Miyaguchi H, Kanamori T, Iwata YT, Inoue H. Interaction of 3,4-methylenedioxymethamphetamine and methamphetamine during metabolism by in vitro human metabolic enzymes and in rats. J Forensic Sci. 2012 Jul;57(4):1008-13. doi: 10.1111/j.1556-4029.2011.02039.x. Epub 2011 Dec 28. PMID: 22211929. 5: Ananda S, Shaohua Z, Fan Y, Liang L. HIV-negative drug addict diagnosed with AIDS and tuberculosis at autopsy: a case report and brief review of literature. J Forensic Leg Med. 2011 Apr;18(3):136-8. doi: 10.1016/j.jflm.2011.01.010. PMID: 21420653. 6: Bánhidy F, Acs N, Puhó EH, Czeizel AE. Hypotension in pregnant women: a population-based case-control study of pregnancy complications and birth outcomes. Hypertens Res. 2011 Jan;34(1):55-61. doi: 10.1038/hr.2010.172. Epub 2010 Sep 30. PMID: 20882028. 7: Bánhidy F, Acs N, Puhó EH, Czeizel AE. Teratogenic potential of pholedrine: a sympathomimetic vasoconstrictive drug - a population-based case-control study. Congenit Anom (Kyoto). 2010 Jun;50(2):122-8. doi: 10.1111/j.1741-4520.2010.00276.x. Epub 2010 Feb 22. PMID: 20184643. 8: Shima N, Kamata HT, Katagi M, Tsuchihashi H. Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats. Xenobiotica. 2006 Feb- Mar;36(2-3):259-67. doi: 10.1080/00498250600627475. PMID: 16702115. 9: Nakajima R, Morishita M, Aiso S, Yajima T. Direct determination of p-hydroxymethamphetamine glucuronide in human urine by high-performance liquid chromatography. Chem Pharm Bull (Tokyo). 2006 Apr;54(4):493-5. doi: 10.1248/cpb.54.493. PMID: 16595951. 10: Kato N, Kubo H, Homma H. Fluorescence analysis of p-hydroxymethamphetamine in urine by thin-layer chromatography. Anal Sci. 2005 Sep;21(9):1117-9. doi: 10.2116/analsci.21.1117. PMID: 16363483. 11: Shima N, Tsutsumi H, Kamata T, Nishikawa M, Katagi M, Miki A, Tsuchihashi H. Direct determination of glucuronide and sulfate of p-hydroxymethamphetamine in methamphetamine users' urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 2;830(1):64-70. doi: 10.1016/j.jchromb.2005.10.014. Epub 2005 Nov 2. PMID: 16263342. 12: Kanamori T, Tsujikawa K, Ohmae Y, Iwata YT, Inoue H, Kishi T, Nakahama T, Inouye Y. A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. Forensic Sci Int. 2005 Mar 10;148(2-3):131-7. doi: 10.1016/j.forsciint.2004.04.084. PMID: 15639607. 13: Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine- derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom. 2003 Jun;38(6):659-76. doi: 10.1002/jms.483. PMID: 12827635. 14: Römhild W, Krause D, Bartels H, Ghanem A, Schöning R, Wittig H. LC-MS/MS analysis of pholedrine in a fatal intoxication case. Forensic Sci Int. 2003 Apr 23;133(1-2):101-6. doi: 10.1016/s0379-0738(03)00055-0. PMID: 12742695. 15: Staack RF, Fehn J, Maurer HH. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jun 5;789(1):27-41. doi: 10.1016/s1570-0232(02)01018-8. PMID: 12726841. 16: Miki A, Katagi M, Tsuchihashi H. Determination of methamphetamine and its metabolites incorporated in hair by column-switching liquid chromatography-mass spectrometry. J Anal Toxicol. 2003 Mar;27(2):95-102. doi: 10.1093/jat/27.2.95. PMID: 12670003. 17: Birchler MT, Landau K, Went PT, Stoeckli SJ. Paraganglioma of the cervical sympathetic trunk. Ann Otol Rhinol Laryngol. 2002 Dec;111(12 Pt 1):1087-91. doi: 10.1177/000348940211101205. PMID: 12498369. 18: Pittasch D, Lobmann R, Behrens-Baumann W, Lehnert H. Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care. 2002 Sep;25(9):1545-50. doi: 10.2337/diacare.25.9.1545. PMID: 12196425. 19: Felscher D, Schulz K. Screening of amphetamine/methamphetamine and their derivatives in urine using FPIA and Triage 8 and the Scope and limits of a subsequent identification by means of the REMEDi HS system. J Forensic Sci. 2000 Nov;45(6):1327-31. PMID: 11110193. 20: al-Dirbashi O, Kuroda N, Menichini F, Noda S, Minemoto M, Nakashima K. Enantioselective high-performance liquid chromatography with fluorescence detection of methamphetamine and its metabolites in human urine. Analyst. 1998 Nov;123(11):2333-7. doi: 10.1039/a804720k. PMID: 10396810.